Govt considers veterinary medicine for treating COVID19

4 weeks ago
308 Views

Government has approved the importation of and use of veterinary medicines as investigational covid19 treatment alternatives.

In a letter seen by community podium dated 26 January 2021, addressed to the Medicines Control Authority of Zimbabwe, Secretary for Ministry of Health and Child Care Dr Mudyiradima said, “In these difficult times of covid19 treatment, we have to be careful to protect the patients as well as not to deny them effective treatment regimes. It is in this regard that authority is hereby granted for you to proceed under section 75 of the Medicines and Allied Substances Control Act to allow importation and use of these medicines under the supervision and guidance you outlined. Ivermectin can be evaluated for both treatment and prophylaxis” read the letter. 

The College of Primary Care Physicians of Zimbabwe (CPCPZ) said Ivermectin, used to treat many types of parasite infestations in animals, and Nanosilver, used for antibacterial and antifungal purposes in water treatment, have shown positive results in the past five months.

Three weeks ago, the Medicines Control Authority of Zimbabwe Acting Director General Mr. Richard Rukwata adopted a cautious stance as he warned members of the public against the use of veterinary ivermectin. 

“In view of the growing number of inquiries ad reports received concerning use of veterinary ivermectin injection for the prevention or treatment of covid19, the Medicines Control Authority of Zimbabwe (MCAZ) is strongly advising members of the public, veterinary medicines general dealers and healthcare practitioners against use of veterinary formulations of ivermectin injection in humans for the prevention or treatment of covid19, or any other health condition,” he said.

Covid19 has sent shock waves in the country prompting citizens to resort to several herbs such as Mzumbane/ uMsuzwane as alternatives in the fight against covid19.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *